Dow Up 0.07% Nasdaq Up 0.61%

Pharmacyclics Inc. (PCYC)

-NasdaqGS
139.33 Up 0.68(0.49%) Nov 26, 4:00PM EST
|After Hours : 135.87 Down 3.46 (2.48%) Nov 26, 5:06PM EST
Prev Close:138.65
Open:138.99
Bid:135.85 x 200
Ask:139.33 x 100
1y Target Est:161.11
Beta:1.36
Next Earnings Date:N/A
Day's Range:137.45 - 139.76
52wk Range:82.51 - 154.89
Volume:289,436
Avg Vol (3m):783,237
Market Cap:10.52B
P/E (ttm):125.52
EPS (ttm):1.11
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PCYC

Comparison

Symbol% ChgMkt Cap
PCYCUp 0.49%10.52B
CTICDown 0.45%323.66M
MRKUp 0.69%170.34B

Key Statistics

Forward P/E (1 yr):497.61
P/S (ttm):18.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.85
Quarterly EPS Est (Dec-14) :0.58
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1,024.50

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes small-molecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback